- 全部删除
您的购物车当前为空
CeMMEC13 是一种异喹啉酮,可选择性抑制 TAF1 的第二个溴结构域,IC50为 2.1 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
CeMMEC13 是一种异喹啉酮,可选择性抑制 TAF1 的第二个溴结构域,IC50为 2.1 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 363 | In stock | |
| 5 mg | ¥ 745 | In stock | |
| 10 mg | ¥ 1,160 | In stock | |
| 25 mg | ¥ 2,480 | In stock | |
| 50 mg | ¥ 3,730 | In stock | |
| 100 mg | ¥ 4,970 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 549 | In stock |
CeMMEC13 相关产品
| 产品描述 | CeMMEC13 is an isoquinolinone that selectively inhibits the second bromodomain of TAF1 (IC50 = 2.1 μM). |
| 靶点活性 | TAF1:2.1 μM |
| 分子量 | 336.34 |
| 分子式 | C19H16N2O4 |
| CAS No. | 1790895-25-8 |
| Smiles | Cn1c2ccccc2c(cc1=O)C(=O)Nc1ccc2OCCOc2c1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 6 mg/mL (17.84 mM), Sonication is recommended. DMSO: 62 mg/mL (184.34 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.95 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容